Indication
Cough
21 clinical trials
28 products
1 drug
Product
CamlipixantClinical trial
A Phase 1, Open-label Study to Investigate the Pharmacokinetics and Safety of Camlipixant in Male and Female Participants Aged 18-75 Years of Age With Hepatic Impairment Compared to Matched Healthy Participants With Normal Hepatic FunctionStatus: Recruiting, Estimated PCD: 2024-07-25
Clinical trial
A Double-Blind, Randomised, Placebo Controlled, Two Period Cross-Over Study to Evaluate the Efficacy and Safety of Orvepitant in Chronic Cough in Patients With Idiopathic Pulmonary FibrosisStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Product
PlaceboProduct
OrvepitantClinical trial
A Phase 1, Single-Centre, Open-Label, Two-Part, Sequential Cross-Over Study Designed to Assess the Pharmacokinetic Profile of BLU-5937 Following Administration of Extended Release Formulation Prototypes and an Immediate Release Reference Formulation in Healthy Male and Female SubjectsStatus: Recruiting, Estimated PCD: 2024-06-28
Product
BLU-5937Product
HS-10383Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-designed Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)Status: Not yet recruiting, Estimated PCD: 2025-09-01
Clinical trial
Clinical Response of Syrup Hydryllin® in Pakistani Subjects With Cough in Routine PracticeStatus: Completed, Estimated PCD: 2023-06-01
Product
HydryllinProduct
Levopront syrupClinical trial
Multicenter Open-label Randomized Clinical Trial of the Efficacy and Safety of Levopront® Syrup 30 mg/5 ml in Comparison With Libexin® 100 mg Tablets in Patients With Dry Non-productive Cough Caused by Acute Upper Respiratory InfectionStatus: Completed, Estimated PCD: 2018-03-06
Product
Libexin®Product
NAL ERClinical trial
Phase 2, Double-blind, Randomized, Placebo-controlled, Two-Treatment, Two-Period Crossover Efficacy and Safety Study in Idiopathic Pulmonary Fibrosis (IPF) With Nalbuphine ER Tablets for the Treatment of CoughStatus: Completed, Estimated PCD: 2022-05-27
Product
Zihua Wenfei ZhisouClinical trial
Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome): a Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical TrialStatus: Recruiting, Estimated PCD: 2023-11-01
Product
BAY1817080Clinical trial
Two-part, Double-blind, Placebo-controlled, Randomized, Parallel-group Study: (Part 1) in Healthy Male Volunteers to Assess Safety and Tolerability of Ascending Repeated Oral Doses of BAY1817080, Followed by (Part 2), Two-way Crossover Administration of Four Different Doses in Patients With Refractory Chronic Cough to Assess Safety, Tolerability and Efficacy for Proof of ConceptStatus: Completed, Estimated PCD: 2019-05-28
Product
Matching PlaceboClinical trial
A Randomized, Double-Blind, Placebo Controlled, Phase Ib Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple-Dose Escalation HS-10383 in Healthy Adult SubjectsStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Cross-over Trial to Evaluate the Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary FibrosisStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
ME-015Clinical trial
Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia : a Single-blinded Randomized Controlled TrialStatus: Completed, Estimated PCD: 2023-11-29
Product
ByfavoProduct
SevofluraneClinical trial
Chronic Cough and CANVAS (Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome): Screening for Mutations in Subunit 1 of the Replication Factor Complex: Initial Pilot StudyStatus: Completed, Estimated PCD: 2023-06-30
Product
RFC1Clinical trial
Alleviation of Upper Respiratory Inflammation and Associated Common Cold SymptomsStatus: Completed, Estimated PCD: 2023-04-08
Product
Aspirin Throat SprayClinical trial
Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol in Individuals With Cough Variant Asthma and Chronic CoughStatus: Recruiting, Estimated PCD: 2024-06-30
Product
MethacholineProduct
Mannitol InhalationClinical trial
Comparison of Bolus Intravenous Lidocaine Administration With Continuous Intravenous Lidocaine Against Post-Extubation Cough Incidence in Post-Thyroidectomy PatientsStatus: Completed, Estimated PCD: 2023-05-01
Product
LidocaineClinical trial
A Cross-sectional Study to Measure Cough in Severe AsthmaStatus: Completed, Estimated PCD: 2019-12-30
Product
Citric acidClinical trial
The Value of FeNO, Blood Eosinophils and TIgE in Predicting the Response to Corticosteroid in Patients With Chronic CoughStatus: Not yet recruiting, Estimated PCD: 2024-03-02
Drug
VarlilumabClinical trial
Office-Based Superior Laryngeal Nerve (SLN) Block for Treatment of Neurogenic CoughStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Pilot Study of Cough Reflex Desensitization for the Treatment of Cough Hypersensitivity SyndromeStatus: Completed, Estimated PCD: 2020-11-30
Product
CapsaicinClinical trial
Influence on Cough and Airway Symptoms by Oral Capsaicin - a Phase 2, Randomised, Placebo-controlled Clinical Study in Patients With Chronic Idiopathic CoughStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
Capsicum OleoresinProduct
Placebos